Last reviewed · How we verify
NCT03960398: EIU
Incidence of Iatrogenic Diseases on Hospital's Emergency Consultations
trial testing Iatrogenic disease impact on emergency consultations in Iatrogenic Disease in 2,500 participants. Completed in 9 September 2019.
9 September 2019
Quick facts
| Lead sponsor | Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 2,500 |
| Start date | 28 June 2019 |
| Primary completion | 9 September 2019 |
| Estimated completion | 9 September 2019 |
| Sites | 2 locations across France |
Drugs / interventions tested
- Iatrogenic disease impact on emergency consultations — full drug profile →
Conditions studied
- Iatrogenic Disease — all drugs for Iatrogenic Disease →
Sponsor
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Who can join
18 and older, any sex, with Iatrogenic Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
French population grows older year after year: 24.3% people were over 60 years old in 2006 against 20.6% in 2000 and the expected number might be over 33% in 2050. The elderly suffer from lots of illnesses, so they usually take lots of drugs. Therefore, this drug use is most likely to have adverse drug reactions. Finally, according to Health Ministry, the number of emergency department consultations doubled from 1996 to 2016. Consequently, it is interesting to study the impact of drug iatrogenic effects on emergency consultations. It would help to prevent these adverse drug reactions as we prescribe those drugs : First, do not harm.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03960398
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer trials
Trials by the same sponsor.
- NCT07355582 — Injury Incidence, Severity and Burden in Elite Youth Rugby Players · recruiting
- NCT06865053 — Screening for Heart Failure in General Medicine Consultations · completed
- NCT06863246 — Postural Control in Chronic Obstructive Pulmonary Disease · completed
- NCT06871670 — Force Control in Chronic Obstructive Pulmonary Disease · completed
- NCT06857396 — Tracheal Exposure Without Tracheostomy Completion in Trans-oral Robotic Oncologic Surgery · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03960398 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
- Last refreshed: 29 November 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03960398.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing